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ABSTRACT Cell entry by coronaviruses involves two principal steps, receptor bind-
ing and membrane fusion; the latter requires activation by host proteases, particu-
larly lysosomal proteases. Despite the importance of lysosomal proteases in both
coronavirus entry and cell metabolism, the correlation between lysosomal proteases
and cell tropism of coronaviruses has not been established. Here, we examined the
roles of lysosomal proteases in activating coronavirus surface spike proteins for
membrane fusion, using the spike proteins from severe acute respiratory syndrome
coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-
CoV) as the model system. To this end, we controlled the contributions from recep-
tor binding and other host proteases, thereby attributing coronavirus entry solely or
mainly to the efficiency of lysosomal proteases in activating coronavirus spike-
mediated membrane fusion. Our results showed that lysosomal proteases from bat
cells support coronavirus spike-mediated pseudovirus entry and cell-cell fusion more
effectively than their counterparts from human cells. Moreover, purified lysosomal
extracts from bat cells cleave cell surface-expressed coronavirus spikes more effi-
ciently than their counterparts from human cells. Overall, our study suggests that
different lysosomal protease activities from different host species and tissue cells are
an important determinant of the species and tissue tropism of coronaviruses.
IMPORTANCE Coronaviruses are capable of colonizing new species, as evidenced by
the recent emergence of SARS and MERS coronaviruses; they can also infect multiple
tissues in the same species. Lysosomal proteases play critical roles in coronavirus en-
try by cleaving coronavirus surface spike proteins and activating the fusion of host
and viral membranes; they also play critical roles in cell physiology by processing
cellular products. How do different lysosomal protease activities from different cells
impact coronavirus entry? Here, we controlled the contributions from known factors
that function in coronavirus entry so that lysosomal protease activities became the
only or the main determinant of coronavirus entry. Using pseudovirus entry, cell-cell
fusion, and biochemical assays, we showed that lysosomal proteases from bat cells
activate coronavirus spike-mediated membrane fusion more efficiently than their
counterparts from human cells. Our study provides the first direct evidence support-
ing lysosomal proteases as a determinant of the species and tissue tropisms of coro-
naviruses.
KEYWORDS coronavirus spike protein, lysosomal proteases, species tropism, tissue
tropism
One of the most outstanding features of viruses is their tropism, including speciesand tissue tropism (1). Viral entry into host cells is among the most important
determinants of viral tropism (2–4). Entry of enveloped viruses involves two steps:
receptor binding and membrane fusion. Enveloped viruses often hijack the endocytosis
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pathway: they enter endosomes, proceed to lysosomes, and then fuse the viral and 
lysosomal membranes. The lysosomes play critical roles in cell metabolism by breaking 
down biomolecules and cellular debris and also by providing nutrients for other cellular 
functions (5, 6). The lysosomal protease activities are central to the functions of 
lysosomes (7). They are also required to activate the membrane fusion of a variety of 
viruses, including coronaviruses and filoviruses (8–11). Understanding the correlation 
between lysosomal protease activities and viral tropism has important implications for 
investigating viral pathogenesis, developing antiviral strategies, and identifying zoo-
notic strains with prepandemic potential.
Coronaviruses are large, enveloped, single-stranded RNA viruses (12, 13). They pose 
significant health threats to humans and other animals. Severe acute respiratory 
syndrome coronavirus (SARS-CoV) was responsible for the SARS epidemic in 2002 and 
2003, causing over 8,000 infections with an 10% fatality rate in humans (14, 15). 
Middle East respiratory syndrome coronavirus (MERS-CoV) was identified in 2012 and 
has so far caused over 2,200 infections with an 35% fatality rate in humans (16, 17). 
An envelope-anchored spike protein guides coronavirus entry into host cells (18, 19). It 
first binds to a receptor on the host cell surface for viral attachment through its S1 
subunit and then fuses viral and host membranes through its S2 subunit. The mem-
brane fusion step by coronavirus spikes requires two prior cleavages by host proteases, 
the first at the S1-S2 boundary (i.e., the S1-S2 site) and the second within S2 (i.e., the 
S2= site) (8, 19–21). Depending on the virus, the spike-processing proteases may come 
from different stages of the coronavirus infection cycle. For MERS-CoV, the spike can be 
processed by proprotein convertases (e.g., furin) during the molecular maturation 
process in virus-producing cells, by cell surface proteases (e.g., transmembrane pro-
tease serine 2 [TMPRSS2]) after viral attachment, and by lysosomal proteases (e.g., 
cathepsins) after endocytosis in virus-targeted cells (22–26). It was previously reported 
that MERS-CoV spike could be processed by furin after viral endocytosis in virus-
targeted cells (21), but this finding was not supported by a recent study (27). The 
protease activation pattern of SARS-CoV entry is similar to that of MERS-CoV, except 
that SARS-CoV spike can also be processed by extracellular proteases (e.g., elastase) 
after virus release (20, 28–30). It has been suggested that the tissue tropisms of 
MERS-CoV and SARS-CoV are correlated with the tissue distributions of proprotein 
convertases, extracellular proteases, and cell surface proteases in the host (22, 23, 26, 
29–31). For example, the availability of trypsin-like proteases in the respiratory tract has 
been suggested to be a determinant of the respiratory tropism of SARS-CoV (29, 30). 
However, although coronavirus entry also depends on lysosomal proteases, it is not 
clear whether the species and tissue tropisms of coronaviruses are correlated with 
different lysosomal protease activities from different hosts or tissue cells.
Both MERS-CoV and SARS-CoV are thought to have originated from bats. SARS-like 
coronaviruses isolated from bats and SARS-CoV isolated from humans are genetically 
highly similar to each other; some of the bat SARS-like coronaviruses recognize the same 
receptor, angiotensin-converting enzyme 2 (ACE2), as human SARS-CoV (32–35). MERS-
like coronaviruses isolated from bats and MERS-CoV isolated from humans so far are also 
genetically similar to each other, albeit not as similar as between bat SARS-like 
coronaviruses and human SARS-CoV (36–39). Several MERS-like coronaviruses from bats, 
including HKU4, recognize the same receptor, dipeptidyl peptidase 4 (DPP4), as MERS-
CoV (24, 40–43). Moreover, human lysosomal proteases activate only MERS-CoV spike, 
but not HKU4 spike, for viral entry into human cells, while bat lysosomal proteases 
activate both MERS-CoV and HKU4 spikes for viral entry into bat cells (44). Furthermore, 
the expression level of lysosomal proteases in human lung cells is lower than in human 
liver cells, leading to inefficient activation of MERS-CoV spike by lysosomal proteases in 
human lung cells (45). These results point to the possibility that lysosomal protease 
activities differ among cells from different hosts or even among cells from the same host 
species, restricting coronavirus entry and their tropism. However, these studies did not 
control the contribution from host receptors, despite the fact that receptor 
homologues from different host species may differ in their
functions as coronavirus receptors or that the same receptor protein may be expressed 
at different levels in different tissues within one host species. Moreover, these studies 
were carried out at the cellular level and did not provide direct biochemical evidence 
to demonstrate that lysosomal proteases from human and bat cells process coronavirus 
spikes differently. Therefore, factor-controlled viral entry data and direct biochemical 
data are both needed to establish the correlation between lysosomal protease activities 
and coronavirus tropism.
In this study, we controlled the contributions of receptor binding and other pro-
teases, and our data support the hypothesis that different lysosomal protease activities 
of bat and human cells impact the efficiency of coronavirus entry into these cells. We 
also purified lysosomal extracts from bat and human cells and showed that bat and 
human lysosomal proteases process coronavirus spikes differently and activate coro-
navirus entry differently. Overall, this study provides the first direct evidence supporting 
the notion that different lysosomal protease activities are an important determinant of 
the species and tissue tropisms of coronaviruses.
RESULTS
Screening for cells that are suitable for studying lysosomal protease-activated 
coronavirus entry. To study lysosomal protease-activated coronavirus entry, we had to 
carefully control the contributions from the host receptor and other intracellular and 
extracellular proteases so that coronavirus spike-mediated viral entry would be solely or 
mainly dependent on the contributions from lysosomal proteases. In other words, we 
partitioned the membrane fusion process from the receptor binding step and also 
separated the effects of lysosomal proteases from those of the other proteases that may 
participate in coronavirus entry. To this end, we screened for cell lines that met the 
following three criteria: (i) the cells from different species or tissues had to endoge-
nously express no or low levels of receptor protein for the coronavirus of interest so 
that they could be controlled to exogenously express the receptor protein from a single 
host species, (ii) the cells had to express no or low levels of cell surface proteases so that 
lysosomal proteases from the cells were the only or the main cellular proteases that 
activated the membrane fusion process for the coronavirus of interest (proprotein 
convertases were not a factor here because the same batch of viruses, which had gone 
through the same molecular maturation process, would be used to infect different 
cells), and (iii) the cells could be transfected easily so that cells from different origins 
could be controlled to express similar levels of the receptor protein from a single host 
species. In sum, we were looking for cells that were both “naked” (i.e., not expressing 
or expressing low levels of coronavirus receptor or cell surface proteases) and easily 
transfectable.
To identify and exclude cells that endogenously expressed coronavirus receptors, 
we performed coronavirus spike-mediated pseudovirus entry in a number of human, 
monkey, and bat cell lines. To this end, retroviruses pseudotyped with MERS-CoV or 
SARS-CoV spike (i.e., MERS-CoV pseudoviruses or SARS-CoV pseudoviruses, respectively) 
were used to test the endogenous levels of receptor expression from different cell lines, 
including human kidney (HEK293T) cells, human cervix (HeLa) cells, human liver (Huh7) 
cells, human lung (A549 and MRC5) cells, monkey kidney (Vero) cells, bat kidney (RSKT 
and BKD9) cells, and bat lung (PESU-B5L and Tb1-Lu) cells. The results showed that 
among these cells, Huh7 cells, Vero cells, MRC5 cells, PESU-B5L cells, and RSKT cells all 
supported significant levels of MERS-CoV pseudovirus entry, suggesting that the cells 
endogenously express significant levels of DPP4 (either human, monkey, or bat DPP4, 
depending on the cell origin) (Fig. 1A). In contrast, only Vero cells and RSKT cells 
supported significant levels of SARS-CoV pseudovirus entry, suggesting that the cells 
endogenously express significant levels of ACE2 (monkey and bat ACE2, respectively)
(Fig. 1B). These results are largely consistent with previous studies, with two exceptions: 
previous studies showed that PESU-B5L cells do not support the infection of MERS-CoV 
and that Huh7 cells support the infection of SARS-CoV (35, 40, 44, 46–48). Overall, the 
cells that endogenously expressed significant levels of DPP4 or ACE2 were not suitable
for studying the roles of lysosomal proteases in coronavirus entry and hence were
excluded from subsequent studies.
FIG 1 Screening for cell lines that are suitable for studying lysosomal protease-activated coronavirus entry. To screen for
cell lines that endogenously express no or low levels of receptor protein for the coronavirus of interest, MERS-CoV
pseudoviruses (A) or SARS-CoV pseudoviruses (B) were used to enter a number of cells from different tissues of different
host species (human, monkey, and bat). Entry efficiency was characterized using luciferase activity accompanying entry
and calibrated against the highest entry efficiency (MERS-CoV entry into MRC5 cells was taken as 100% in panel A, whereas
SARS-CoV entry into Vero cells was taken as 100% in panel B). Mock, no pseudoviruses were added. The error bars indicate
standard errors of the mean (SEM) (n  5). (C) To screen for cell lines that could be easily transfected and hence controlled
to exogenously express receptor protein for the coronavirus of interest, different cells were transfected with a plasmid
encoding human DPP4 (hDPP4); subsequently, the expression level of human DPP4 in each of the cell lines was detected
through Western blotting using an antibody recognizing its C-terminal C9 tag. The expression level of -actin in each of
the cell lines was used as a positive control. (D) MTT cell viability assay, showing that the viabilities of three types of cells
were not affected by the presence of different protease inhibitors. The error bars indicate SEM (n  5). OD570, optical
density at 570 nm. There was no statistical significance under different conditions within each cell group (P  0.05, based
on a two-tailed t test).
To investigate which of the cells could be controlled to exogenously express 
significant levels of coronavirus receptors, we transfected the cells with a plasmid 
encoding human DPP4 and then performed Western blotting using an antibody 
recognizing the C-terminal C9 tag of exogenously expressed human DPP4 in the cells 
(Fig. 1C). The results showed that (i) HEK293T cells, HeLa cells, and Tb1-Lu cells 
exogenously express significant levels of human DPP4; (ii) Huh7 cells, A549 cells, Vero 
cells, and MRC5 cells exogenously express low levels of human DPP4; and (iii) PESU-B5L 
cells, RSKT cells, and BKD9 cells do not exogenously express human DPP4. Therefore, 
HEK293T, HeLa, and Tb1-Lu cells were selected for downstream studies designed to 
evaluate the roles of lysosomal proteases in coronavirus entry because they met two of 
the three above-mentioned criteria: they are naked without endogenously expressing 
coronavirus receptors, and they are easily transfectable and hence can be controlled to 
exogenously express coronavirus receptors. In addition, an MTT [3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide] cell viability assay showed that the 
viability of these three types of cells was not affected by the presence of different 
protease inhibitors, allowing the use of the protease inhibitors in characterizing the 
roles of different proteases in coronavirus entry (Fig. 1D). Furthermore, as shown below, 
they are also naked, with no or low endogenous expression of cell surface proteases. 
Characterization and selection of these cells laid the foundation for defining the roles 
of lysosomal proteases in coronavirus entry.
Lysosomal proteases from human and bat cells activate coronavirus spike-
mediated membrane fusion differently. To examine the roles of lysosomal proteases 
in MERS-CoV spike-mediated membrane fusion, we performed MERS-CoV pseudovirus 
entry in the three model cell lines where exogenous expression of human DPP4 can be
FIG 2 Roles of lysosomal proteases in MERS-CoV spike-mediated membrane fusion. (A) Roles of lyso-
somal proteases in MERS-CoV pseudovirus entry. Three types of cells, h-HEK293T, h-HeLa, and b-Tb1-Lu, 
were controlled to exogenously express human DPP4 as shown in Fig. 1C and then subjected to 
MERS-CoV pseudovirus entry as shown in Fig. 1A. The furin inhibitor chloromethyl ketone, the cell surface 
protease (i.e., TMPRSS2) inhibitor camostat, and the lysosomal protease (i.e., cathepsin) inhibitor E64d 
were used in parallel experiments to investigate the relative contributions of the different proteases to 
MERS-CoV pseudovirus entry. The expression levels of cell surface-associated C9-tagged human DPP4 
were measured through Western blot analysis using an anti-C9 tag monoclonal antibody and were 
further calibrated across the three types of cells. (B) MERS-CoV spike-mediated cell-cell fusion in the 
presence of lysosomal extracts. h-HEK293T cells exogenously expressing MERS-CoV spike and h-HEK293T 
cells exogenously expressing human DPP4 were mixed at pH 5.6 in the presence of lysosomal extracts 
from h-HEK293T cells, h-HeLa cells, b-Tb1-Lu cells, or b-BKD9 cells. Cell-cell fusion efficiency was 
characterized using luciferase activity accompanying fusion and calibrated against the highest fusion 
efficiency (i.e., in the presence of lysosomal extracts from b-Tb1-Lu cells). Three negative controls were 
used: (i) cells not expressing human DPP4 were used (No receptor); (ii) no lysosomal proteases were 
added to the medium, and the medium was at neutral pH (No treatment); (iii) no lysosomal proteases 
were added, but the medium was at pH 5.6 (Low pH treatment). Statistical analyses were performed 
using a two-tailed t test. The error bars indicate SEM (n  4). ***, P  0.001; **, P  0.01.
measured and calibrated: human HEK293T (h-HEK293T) cells, human HeLa (h-HeLa)
cells, and bat Tb1-Lu (b-Tb1-Lu) cells. The results showed that all three types of cells
supported MERS-CoV pseudovirus entry at significant levels when they exogenously
expressed human DPP4 (Fig. 2A). When the expression levels of cell surface-associated
human DPP4 were measured and calibrated across the three types of cells (Fig. 2A),
b-Tb1-Lu cells supported MERS-CoV pseudovirus entry more efficiently than both
h-HEK293T cells and h-Hela cells. Because no extracellular protease was added to the
pseudovirus entry assay mixture, these data suggest that cellular proteases were
responsible for the high efficiency of b-Tb1-Lu cells in activating MERS-CoV pseudovirus
entry. MERS-CoV pseudovirus entry in the presence of different cellular protease
inhibitors showed that lysosomal protease (i.e., cathepsin) inhibitor almost completely
inhibited MERS-CoV pseudovirus entry into the cells, whereas proprotein convertase
(i.e., furin) inhibitor and cell surface protease (i.e., TMPRSS2) inhibitor had much less
h-HEK293T cells and h-HeLa cells.
impact on the efficiency of the cells in supporting MERS-CoV pseudovirus entry 
(Fig. 2A). Thus, lysosomal proteases were mainly responsible for MERS-CoV pseudovirus 
entry into the cells. Therefore, after the contributions from host receptor and other 
proteases were controlled, lysosomal proteases from b-Tb1-Lu cells supported MERS-
CoV spike-mediated membrane fusion more efficiently than their counterparts from
To further demonstrate that different lysosomal protease activities directly impact 
MERS-CoV spike-mediated membrane fusion, we performed MERS-CoV spike-mediated 
cell-cell fusion in the presence of purified lysosomal extracts from different cells. To this 
end, we purified lysosomal extracts from h-HEK293T cells, h-HeLa cells, b-Tb1-Lu cells, 
and bat BKD9 (b-BKD9) cells. Subsequently, we mixed one batch of h-HEK293T cells 
exogenously expressing MERS-CoV spike and another batch of h-HEK293T cells exog-
enously expressing human DPP4. Then, we added the same amount (i.e., mass) of each 
of the lysosomal extracts to the mixture of the above-mentioned h-HEK293T cells while 
reducing the pH of the cell culture medium to the level at which lysosomal proteases 
were active (i.e., pH 5.6). As we showed earlier, h-HEK293T cells do not endogenously 
express significant amounts of cell surface proteases (Fig. 2A). Hence, the efficiency of 
cell-cell fusion likely reflects the activation of MERS-CoV spike-mediated membrane 
fusion by purified lysosomal extracts from different types of cells. The results showed 
that lysosomal extracts from b-Tb1-Lu cells and b-BKD9 cells both activate MERS-CoV 
spike-mediated cell-cell fusion more efficiently than their counterparts from h-HEK293T 
cells and h-HeLa cells (Fig. 2B). In comparison, in the absence of any lysosomal extracts, 
there was no significant cell-cell fusion at neutral pH and only low levels of cell-cell 
fusion at low pH, suggesting that pH alone has little or no effect on MERS-CoV 
spike-mediated cell-cell fusion (Fig. 2B). Therefore, consistent with the MERS-CoV 
pseudovirus entry assay results, the cell-cell fusion assay also revealed that lysosomal 
extracts from bat cells support MERS-CoV spike-mediated membrane fusion more 
efficiently than their counterparts from human cells.
To examine the purity of the lysosomal extracts, we investigated potential contam-
ination of the lysosomal extracts by proteins from plasma or the endoplasmic reticulum 
(ER). Because alkaline phosphatase (ALP) and cytochrome P450 reductase (CPR) are 
markers of plasma enzymes and ER enzymes, respectively, their activities in lysosomal 
extracts are commonly used as indicators of the purity of lysosomal extracts (49). 
Hence, we measured the ALP and CPR activities of the lysosomal extracts from 
different cell lines (Fig. 3A and B). The results showed that, compared to the 
whole-cell lysates, the ALP and CPR activities in the lysosomal extracts were low (for 
some unknown reason, the ALP activities of BKD9 cells were very low). Thus, based 
on the indicator proteins, the contamination of the lysosomal extracts by plasma 
and ER proteins was low.
To extend the above-described findings from MERS-CoV to other coronaviruses, we 
investigated whether lysosomal proteases from human and bat cells activate SARS-CoV 
spike-mediated membrane fusion differently, also after controlling the contributions 
from host receptor and other proteases. To this end, we performed SARS-CoV pseu-
dovirus entry into h-HEK293T cells, h-HeLa cells, and b-Tb1-Lu cells, all of which were 
controlled to exogenously express human ACE2. The results showed that, like MERS-
CoV pseudoviruses, SARS-CoV pseudoviruses entered b-Tb1-Lu cells more efficiently 
than they did h-HEK293T and h-HeLa cells (Fig. 4A). Lysosomal protease inhibitor 
almost completely inhibited SARS-CoV pseudovirus entry into these cells, while pro-
protein convertase inhibitor and cell surface protease inhibitor had much less impact 
on SARS-CoV pseudovirus entry into the cells. Hence, lysosomal proteases were the 
main contributor to SARS-CoV pseudovirus entry into the cells. Moreover, we carried 
out SARS-CoV spike-mediated cell-cell fusion in the presence of lysosomal extracts from 
h-HEK293T cells, h-HeLa cells, b-Tb1-Lu cells, or b-BKD9 cells. The results showed that 
lysosomal extracts from bat cells activated SARS-CoV spike-mediated cell-cell fusion 
more efficiently than their counterparts from human cells (Fig. 4B). Taken together, our 
data support the hypothesis that lysosomal proteases from bat cells support SARS-CoV
spike-mediated membrane fusion, in the forms of both pseudovirus entry and cell-cell
fusion, more efficiently than their counterparts from human cells.
Lysosomal proteases from human and bat cells process MERS-CoV spike dif-
ferently. To provide direct biochemical evidence supporting the notion that lysosomal
FIG 3 Characterization of the purity of lysosomal extracts from different cell lines. Because ALP and CPR
are enzymatic markers of plasma and the ER, respectively, the purified lysosomal extracts and whole-cell
lysates from different cell lines (for each cell line, lysosomal extracts and whole-cell lysates were at equal
concentrations) were assayed for their ALP activities (A) and CPR activities (B) to evaluate potential
contaminants from other cell organelles. The error bars indicate SEM (n  3; some of the error bars may
be too small to be seen).
FIG 4 Roles of lysosomal proteases in SARS-CoV spike-mediated membrane fusion. The experiments 
were performed in the same way as for Fig. 2, except that SARS-CoV spike and its receptor, human ACE2 
(hACE2), replaced MERS-CoV spike and human DPP4, respectively.
FIG 5 Cleavage of cell surface-expressed MERS-CoV spike using purified lysosomal extracts. (A) Cleavage of cell
surface-expressed MERS-CoV spike using lysosomal extracts from a number of cell lines. MERS-CoV spike was
exogenously expressed on the surfaces of h-HEK293T cells and then treated with 50 g/ml lysosomal extracts (from
different types of cells) at pH 5.6 for 30 min. The cleavage state of MERS-CoV spike was detected through Western
blotting using an antibody recognizing its C-terminal C9 tag. (B) Cleavage of cell surface-expressed MERS-CoV spike
using 100 g/ml lysosomal extracts (from two types of cells) at pH 5.6 in a time-dependent manner (10, 30, and
60 min). The experiments were repeated five times, and representative results are shown.
proteases from human and bat cells process MERS-CoV spike differently, we digested 
cell surface-expressed MERS-CoV spike using lysosomal extracts from human and bat 
cells. To this end, we exogenously expressed MERS-CoV spike on the surfaces of 
h-HEK293T cells. Meanwhile, we purified lysosomal extracts from different types of 
human and bat cells. Then, we incubated the cell surface-expressed MERS-CoV spike 
with the same amount of lysosomal extracts from each type of cell, and we performed 
Western blotting to detect the cleavage state of MERS-CoV spike. The results showed 
that more than half of the MERS-CoV spike molecules had been cleaved to S2 by 
proprotein convertases during the molecular maturation process and that lysosomal 
extracts from bat cells were more efficient than their counterparts from human cells in 
further cleaving MERS-CoV spike to produce S2= fragments (Fig. 5A). Between the two 
types of bat cells, lysosomal extracts from b-BKD9 cells processed MERS-CoV spike more 
efficiently than their counterparts from b-Tb1-Lu cells. We further compared the 
lysosomal extracts from b-BKD9 cells and their counterparts from h-HEK293T cells; 
lysosomal extracts from b-BKD9 cells processed MERS-CoV spike much more efficiently 
than their counterparts from h-HEK293T cells in a time-dependent manner (Fig. 5B). 
Overall, lysosomal extracts from bat cells demonstrated higher efficiency in processing 
MERS-CoV spike than their counterparts from human cells.
To further compare the coronavirus spike-processing activities of human and bat 
lysosomal proteases, we examined whether lysosomal extracts from human and bat 
cells process the spike from a MERS-like bat coronavirus, HKU4, differently. Previously, 
we showed that HKU4 spike contains a glycosylated lysosomal protease site at the 
S1-S2 boundary and that it mediates virus entry into bat cells, but not human cells (44). 
Here, we investigated direct biochemical evidence for the different HKU4 spike-
processing activities of human and bat lysosomal proteases. To this end, we purified 
lysosomal extracts from h-HEK293T cells and b-Tb1-Lu cells and incubated them 
individually with HKU4 spike expressed on the surfaces of h-HEK293T cells. The results 
showed that lysosomal extracts from b-Tb1-Lu cells, but not their counterparts from 
h-HEK293T cells, cleaved HKU4 spike containing a glycosylated lysosomal protease 
motif to produce S2 (Fig. 6A). Next, we introduced an N762A mutation into HKU4 spike; 
the mutation had been shown to remove the glycosylation from the lysosomal pro-
tease motif in HKU4 spike (44). The result showed that lysosomal extracts from both 
h-HEK293T cells and b-Tb1-Lu cells cleaved the mutant HKU4 spike to produce S2
FIG 6 Cleavage of cell surface-expressed HKU4 spike using purified lysosomal extracts. The experiments 
were performed in the same way as for Fig. 5A, except that HKU4 spike (either wild type [WT] or 
containing an N762 mutation that removed a glycosylation site from the lysosomal protease motif) 
replaced MERS-CoV spike. The experiments were repeated five times, and representative results are 
shown.
(Fig. 6B). These results provided direct biochemical evidence demonstrating that 
lysosomal extracts from b-Tb1-Lu cells, but not their counterparts from h-HEK293T cells, 
can process the glycosylated lysosomal protease motif in HKU4 spike, whereas lyso-
somal extracts from both h-HEK293T cells and b-Tb1-Lu cells can process the ungly-
cosylated lysosomal protease motif in HKU4 spike.
DISCUSSION
The tropism of coronaviruses includes species and tissue tropisms (1). Lysosomal 
proteases play a critical role in coronavirus entry (8, 10, 11), but their roles in corona-
virus tropism have not been established. In contrast, extracellular proteases and other 
cellular proteases have been shown to be important determinants of coronavirus 
tropism (22, 23, 26, 29–31). We and others previously showed that a MERS-like coro-
navirus from bats, HKU4, uses the same host receptor, DPP4, as MERS-CoV (24, 41), and 
we also showed that cellular proteases from bat and human cells support HKU4 entry 
differently (24, 44). However, two factors can complicate the roles of lysosomal pro-
teases in coronavirus tropism: human and bat DPP4 molecules have different activities 
as coronavirus receptors, and other proteases may also play significant roles in the cell 
entry process of coronaviruses. In the current study, we quantified and controlled the 
contributions from host receptor and other proteases to coronavirus entry so that the 
roles of lysosomal proteases in coronavirus entry into cells from different origins could 
be clearly defined. To this end, we screened a number of cell lines originating from 
different tissues and host species and found three types of cells that were suitable for 
studying the roles of lysosomal proteases in coronavirus tropism: human HEK293T cells, 
human HeLa cells, and bat Tb1-Lu cells. These three types of cells share the following 
common features: they are naked for endogenously expressing very low levels of 
coronavirus receptor or cell surface proteases, and they can be easily transfected to 
exogenously express the coronavirus receptor from a single host species. As a result, 
lysosomal proteases likely function as the only or the main contributor to coronavirus 
spike-mediated entry. The above-described approach and findings may be extended to 
study the roles of lysosomal proteases in the entry of other viruses.
The current study investigated the roles of lysosomal proteases from the above-
mentioned human and bat cells in coronavirus entry using a combination of pseudo-
virus entry, cell-cell fusion, and biochemical assays. To this end, we exogenously 
expressed human DPP4 in different types of cells and performed MERS-CoV spike-
mediated pseudovirus entry and cell-cell fusion. In the presence of DPP4 from the same 
species and in the absence of extracellular proteases and other cellular proteases, 
lysosomal proteases and lysosomal extracts from bat cells supported MERS-CoV spike-
mediated membrane fusion more efficiently than their counterparts from human cells.
These observations were then extended to SARS-CoV spike-mediated pseudovirus 
entry and cell-cell fusion. Moreover, we prepared lysosomal extracts from human and 
bat cells and showed that lysosomal extracts from bat cells cleaved MERS-CoV spike 
more efficiently than their counterparts from human cells. We also showed that 
lysosomal extracts from bat cells cleaved HKU4 spike, which contains a glycosylated 
lysosomal protease motif, more efficiently than their counterparts from human cells. 
These results demonstrated that the spikes from MERS-CoV, SARS-CoV, and HKU4 all 
mediated viral entry into bat cells at higher efficiency than into human cells, due to or 
mainly due to the higher coronavirus spike-processing activities of bat lysosomal 
proteases.
The correlation between lysosomal protease activities and coronavirus tropism is a 
novel finding in virology. Previous studies had already shown that the expression levels 
of lysosomal proteases vary among different tissues within the same host species due
to the different physiological functions of the tissue cells (7, 45). Our study demon-
strates that lysosomal protease activities may also vary among different mammalian 
species, indicating that adaptation of coronaviruses to new species may occur through 
adaptation to different lysosomal protease activities. The physiological reason for 
different lysosomal protease activities among mammalian species is not clear, but it 
could be due to the different lifestyles of these species. For instance, bats are the only 
flying mammals, and hence, the enhanced lysosomal protease activities of bat cells may 
provide fast turnover of metabolic products and also produce high levels of nutrients, 
although this is speculative. In this sense, supporting coronavirus entry efficiently could 
be a by-product of the enhanced lysosomal protease activities of bat cells. It is worth 
noting that, due to the difficulty in culturing bat tissue cells, this study was performed 
using bat cell lines. Although cell lines usually maintain many features of original tissue 
cells, these findings need to be confirmed using bat tissue cells. Our study suggests that 
no matter whether cells are from different host species or from different tissues of the 
same host species, cells with higher lysosomal protease activities in general support 
coronavirus entry more efficiently than cells with lower lysosomal protease activities. It 
remains to be further investigated whether the higher lysosomal protease activities in 
some cells are due to enhanced enzymatic activity, elevated expression levels, or other 
changes to their lysosomal proteases. Nevertheless, our study has established that 
different lysosomal proteases from different types of cells have direct impacts on 
coronavirus entry, which has implications for the tissue and species tropism of coro-
naviruses.
MATERIALS AND METHODS
Cell lines and plasmids. HEK293T cells (human embryonic kidney cells), HeLa cells (human cervical 
epithelial cells), A549 cells (human alveolar epithelial cells), Vero cells (monkey kidney cells), MRC5 cells 
(human lung cells), and Tb1-Lu cells (Triatoma brasiliensis bat lung cells) were obtained from the ATCC 
(American Type Culture Collection). RSKT cells (Rhinolophus sinicus bat kidney cells), PESU-B5L cells 
(Perimyotis subflavus bat lung cells), and BKD9 cells (Myotis davidii bat kidney cells) were purchased from 
Sigma-Aldrich. Huh-7 cells (human hepatoma cells) were kindly provided by Charles M. Rice (Rockefeller 
University). All the cells were cultured in Dulbecco’s modified Eagle medium (DMEM) supplemented with 
10% fetal bovine serum (FBS), 2 mM L-GLUTAMINE, 100 units/ml penicillin, and 100 g/ml streptomycin 
(Life Technologies). The full-length genes of MERS-CoV spike (GenBank accession number AFS88936.1), 
SARS-CoV spike (GenBank accession number AFR58742), human DDP4 (GenBank accession number 
NM_001935.3) and human ACE2 (GenBank accession number NM_021804) were synthesized (GenScript 
Biotech) and subcloned into the pcDNA3.1() vector (Life Technologies) with a C-terminal C9 tag (i.e., a 
tag corresponding to the 9 amino acids at the C terminus of human complement component C9 protein). 
Plasmids (pFR-Luc and pBD-NF-B) for cell-cell fusion were kindly provided by Zhaohui Qian (Chinese 
Academy of Medical Sciences and Peking Union Medical College).
Coronavirus spike-mediated pseudovirus entry into human and bat cells. Retroviruses pseu-
dotyped with MERS-CoV or SARS-CoV spike (i.e., MERS-CoV pseudoviruses or SARS-CoV pseudoviruses, 
respectively) were generated as described previously (24). Briefly, HEK293T cells were cotransfected with 
a plasmid carrying an Env-defective, luciferase-expressing HIV-1 genome (pNL4 –3.luc.R-E-) and a 
pcDNA3.1() plasmid encoding MERS-CoV or SARS-CoV spike. Pseudoviruses were harvested 72 h after 
transfection and used to enter human and bat cells. For screening of cell lines expressing no or low levels 
of coronavirus receptor, different types of cells were seeded in 96-well plates and infected immediately 
with pseudoviruses. To study the roles of lysosomal proteases in coronavirus entry, cells were transfected 
with the pcDNA3.1() plasmid encoding human DPP4 or human ACE2; 24 h after the transfection, the
cells expressing the receptor were seeded in 96-well plates and then infected with pseudoviruses. After 
incubation at 37°C for 6 h, the medium was replaced with fresh DMEM. After another 60 h, the cells were 
washed with phosphate-buffered saline (PBS) and lysed. Aliquots of the cell lysates were transferred to 
an Optiplate-96 plate (PerkinElmer Life Sciences), and then luciferase substrate (Promega) was added. 
Relative luciferase units were measured using an EnSpire plate reader (PerkinElmer Life Sciences) and 
normalized for exogenous expression levels of the corresponding receptor in the cell membranes (see 
below).
Inhibition of pseudovirus entry using various protease inhibitors was carried out as described 
previously (50). Briefly, target cells were preincubated with medium containing a final concentration of 
50 M camostat mesylate (Sigma-Aldrich), 50 M E-64d (Sigma-Aldrich), 50 M chloromethyl ketone 
(Enzo), or DMSO (dimethyl sulfoxide) (negative control) at 37°C for 1 h. The cells were subsequently 
infected with pseudoviruses. The cells were incubated at 37°C for 6 to 8 h, and then the medium was 
replaced with fresh DMEM. After another 48 h, the cells were lysed and measured for luciferase activity.
Exogenous expression of coronavirus receptor in cells and on cell surfaces. To examine the 
exogenous expression level of coronavirus receptor in whole-cell lysates, cells were transfected with 
pcDNA3.1() plasmid encoding human DPP4 or human ACE2 containing a C-terminal C9 tag; 48 h after 
transfection, the cells were lysed using ultrasonication, and aliquots of cell lysates were subjected to 
Western blotting. The C9-tagged coronavirus receptors were detected using an anti-C9 tag monoclonal 
antibody (Santa Cruz Biotechnology). The current assay measures the total expression level of corona-
virus receptor in a certain number of cells without specifying how many of the cells were transfected or 
how much protein was expressed in each transfected cell.
To examine the exogenous expression level of coronavirus receptor in cell membranes, the cells 
expressing the receptor were harvested as described above, and all membrane-associated proteins were 
extracted using a membrane protein extraction kit (Thermo Fisher Scientific). Briefly, cells were centri-
fuged at 300  g for 5 min and washed with cell wash solution twice. The cell pellets were resuspended 
in 0.75 ml permeabilization buffer and incubated at 4°C for 10 min. The supernatant containing cytosolic 
proteins was removed after centrifugation at 16,000  g for 15 min. The pellets containing membrane-
associated proteins were resuspended in 0.5 ml solubilization buffer and incubated at 4°C for 30 min. 
After centrifugation at 16,000  g for 15 min, the membrane-associated proteins from the supernatant 
were transferred to a new tube. The expression level of membrane-associated C9-tagged coronavirus 
receptor among the membrane-associated proteins was then measured using Western blot analysis as 
described above and used for normalizing the results from pseudovirus entry assays. Although the 
current assay could not differentiate between plasma membrane-associated proteins and internal-
membrane-associated proteins, ACE2 and DPP4 are known to be strongly associated with plasma 
membranes due to their respective plasma membrane-targeting signal peptides (51, 52).
MTT assay. Cells were seeded in 96-well plates and treated with DMSO or protease inhibitors 
dissolved in DMSO at 37°C. After incubation for 6 h, the medium was replaced with fresh DMEM. After 
incubation for 70 h at 37°C, 10 l MTT solution (Biotium) was added to each well and mixed with the 
medium. After incubation at 37°C for 2 h, 200 l DMSO or protein inhibitor dissolved in DMSO was added 
to each well and mixed with the medium. The MTT signal was measured as absorbance at 570 nm using 
a Synergy 2 multimode microplate reader (BioTek Instruments).
Preparation of lysosomal extracts. Lysosomal extracts from human or bat cells were prepared 
according to the lysosome isolation kit procedure (Sigma-Aldrich). Briefly, cells were harvested and 
washed with PBS buffer and then resuspended in 2.7 packed cell volumes (PCV) of extraction buffer. The 
cells were broken in a 7-ml Dounce homogenizer using a loose pestle (i.e., pestle B) until 80% to 85% of 
the cells were broken (protease inhibitors from the kit were omitted in our procedure). The samples were 
centrifuged at 1,000  g for 10 min, and the supernatants were transferred to a new centrifuge tube and 
centrifuged at 20,000  g for another 20 min. The supernatants were removed, and the pellets were 
resuspended in extraction buffer as the crude lysosomal fraction (CLF). The CLF was diluted in buffer 
containing 19% Optiprep density gradient medium solution and further purified using density gradient 
centrifugation at 150,000  g for 4 h to yield lysosomal extracts. The concentrations of the lysosomal 
extracts were measured using a NanoDrop 8000 (Thermo Fisher Scientific) and calculated according to 
their absorbance at 280 nm. The purities of the lysosomal extracts were examined using the assays 
described below.
CPR is an ER marker. For evaluation of the potential contamination of the purified lysosomal extracts 
by ER proteins, the cytochrome P450 reductase activities of the purified lysosomal extracts were 
measured using a cytochrome P450 reductase assay kit (Biovision). Briefly, a glucose-6-phosphate (G6P) 
standard curve was first calculated by mixing a series of volumes of 1 mM G6P standard solution with 5 l 
NADPH substrate and 5 l G6P standard developer to make the final volume 100 l/well. The well 
contents were then mixed and incubated at room temperature for 30 min (protected from light). 
Absorbance at 460 nm was measured. Then, 5 l lysosomal extracts from different cell lines was mixed 
with 55 l CPR assay buffer. After adding 30 l of the assay reaction mixture to each well and incubating 
the solutions at room temperature for 5 min, 10 l of the 20 mM G6P solution was added to each well. 
Absorbance at 460 nm was measured immediately in kinetic mode at 25°C for 25 min using a Synergy 2 
multimode microplate reader (BioTek Instruments). Calculation of the cytochrome P450 reductase 
activity was performed according to the manufacturer’s manual.
ALP is a plasma enzyme marker. For evaluation of the potential contamination of the purified 
lysosomal extracts by plasma proteins, the alkaline phosphatase activity of the purified lysosomal 
extracts was measured using an alkaline phosphatase assay kit (Abnova). Briefly, a standard curve was 
first calculated by mixing a series of concentrations of 4-methylumbelliferyl phosphate disodium salt
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(MUP) standard with 10 l ALP enzyme solution. The reaction mixtures were incubated at 25°C for 30 min 
(protected from light). The ALP enzyme can convert MUP substrate to an equal molar amount of 
fluorescent 4-methylumbelliferone (4-MU). Hence, 20 l 0.5 mM MUP substrate solution was added to 
each well containing 5 l lysosomal extracts from different cell lines. After mixing and incubating at 25°C 
for 30 min (protected from light), all the reactions were stopped by adding 20 l stop solution to each 
reaction mixture. Then, the fluorescence intensities at excitation and emission wavelengths of 360 and 
440 nm, respectively, were measured using a Synergy 2 multimode microplate reader (BioTek Instru-
ments). Calculation of the alkaline phosphatase activity was performed according to the manufacturer’s 
manual.
Coronavirus spike-mediated cell-cell fusion. Cell-cell fusion was performed as described previ-
ously (53). Briefly, to produce cells expressing one of the coronavirus spikes, HEK293T cells were 
cotransfected with the plasmid pFR-Luc, which contains a synthetic promoter with five tandem repeats 
of the Saccharomyces cerevisiae GAL4 binding sites that controls expression of the luciferase gene, and 
the pcDNA3.1() plasmid encoding one of the coronavirus spikes. To produce cells expressing one of the 
corresponding coronavirus receptor proteins, HEK293T cells were cotransfected with pBD-NF-B, which 
encodes a fusion protein with the DNA binding domain of GAL4 and the transcription activation domain 
of NF-B, and a pcDNA3.1() plasmid encoding one of the corresponding coronavirus receptor proteins. 
After culturing for 24 h, the spike-expressing HEK293T cells were lifted, centrifuged, and then resus-
pended in low-pH medium containing 10 mM sodium citrate, pH 5.6. Subsequently, the spike-expressing 
HEK293T cells were treated with purified lysosomal extracts (100 g/ml) in the low-pH medium. After 
incubation at 37°C for 30 min, the spike-expressing cells were centrifuged, resuspended in fresh neutral 
pH medium, and then overlaid onto receptor-expressing HEK293T cells at a ratio of 1:2. When cell-cell 
fusion occurred, the expression of the luciferase gene was activated through binding of the GAL4 –NF-B 
fusion protein to GAL4 binding sites at the promoter of the luciferase gene. After incubation for 24 h, the 
cells were lysed, aliquots of the cell lysates were transferred to an Optiplate-96 plate (PerkinElmer Life 
Sciences), and then luciferase substrate (Promega) was added. Relative luciferase units were measured 
using an EnSpire plate reader (PerkinElmer Life Sciences).
Cleavage of coronavirus spikes using purified lysosomal extracts. HEK293T cells were transfected 
with pcDNA3.1() plasmid encoding MERS-CoV spike or HKU4 spike; 48 h after transfection, the cells 
were harvested and washed with PBS buffer. The cells were then treated with 50 g/ml purified 
lysosomal extracts at pH 5.6 for 30 min or 100 g/ml purified lysosomal extracts at pH 5.6 for different 
periods of time (i.e., 10, 30, or 60 min). After treatment, the cells were lysed and boiled for Western 
blotting. The C9-tagged spikes were detected using an anti-C9 tag monoclonal antibody (Santa Cruz 
Biotechnology).
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